PTC Therapeutics (PTCT) Earnings Date & Reports

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PTCT is expected to report earnings to fall 110.66% to -107 cents per share on July 31

PTC Therapeutics PTCT Stock Earnings Reports

Q2'25

Est.

$-1.07

Q1'25

Beat

by $11.07

Q4'24

Missed

by $0.06

Q3'24

Beat

by $0.12

Q2'24

Missed

by $0.17

The last earnings report on May 06 showed earnings per share of $10.04, beating the estimate of -102 cents. With 1.09M shares outstanding, the current market capitalization sits at 3.68B.

View a ticker or compare two or three

Compare

PTCT